The Form 4 filing, an SEC report of insider stock activity, was filed on November 17, 2026. It lists November 13 as the earliest transaction date and November 16 as the latest. These are the sale dates, separate from the date the report was filed.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-13 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 20,000 |
| Price | $35.03 |
| Total Transaction Value | $700,700.00 |
| Insider | |
| Ticker Symbol | TRUP |
| Company | TRUPANION, INC. |
| Insider Name | RUBIN HOWARD E |
| Insider Title | Director |
| Sector - Industry | Financial Services - Insurance - Property & Casualty |
| Holdings | |
| Total Shares Owned After Transaction | 183,288 |
| Position Size Change | 9.84% |
| Filing | |
| Filing Date | 2026-11-17 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of Trupanion (TRUP) shares, reported under transaction code S. Howard E. Rubin, a company director, reported two sale transactions in this single filing.
What was the average price of the transaction?
The average sale price was $35.035 per share across both transactions. The table displays $35.03 per share, a half-cent difference. Separate prices for each sale were not provided.
How did this transaction affect the insider's holdings?
He sold 20,000 shares and reported owning 183,288 shares afterward. The shares sold represented 9.84% of his reported shares owned before the sales. A reported share balance remained after the sales.
What's the total transaction value?
The total value was $700,700.00 for both sales together, stated to the nearest cent. Separate dollar values for each sale were not provided.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnotes were not available for this report, so any further terms or explanations remain unknown. The information also does not state why the director sold.
For research purposes only; not investment advice.